Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 22 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 8367691

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  2. US 8367660

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  3. US 8367697

    Kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  4. US 8362253

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  5. US 8362032

    Bicyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  6. US 8362043

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  7. US 8357702

    Bicyclic derivatives as modulators of voltage gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted
  8. US 8354427

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted
  9. US 8354419

    Benzimidazole analogues for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted
  10. US 8344147

    Process for preparing modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  11. US 8343980

    Quinazoles useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  12. US 8344153

    Inhibitors of phosphatidylinositol 3-kinase

    Vertex Pharmaceuticals Incorporated · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  13. US 8343763

    Heterocyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  14. US 8343998

    Triazolothiadiazole inhibitor of c-Met protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  15. US 8338597

    Pyridones useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  16. US 8338412

    Inhibitors of P38

    Vertex Pharmaceuticals Incorporated · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  17. US 8329662

    Prodrug of an ICE inhibitor

    Vertex Pharmaceuticals Incorporated · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  18. US 8329702

    Heterocycles useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  19. US 8324207

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  20. US 8324220

    Pyrimidines useful as modulators of voltage-gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  21. US 8324242

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  22. US 8318467

    Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

    Vertex Pharmaceuticals Incorporated · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted
  23. US 8318733

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted
  24. US 8314141

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Vertex Pharmaceuticals Incorporated · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted